Paraneoplastic Syndrome in Splenic Marginal Zone Lymphoma: A Rare Phenomenon of Paraplegia as an Atypical Presenting Manifestation [PDF]
, 2016 Jessica Schering +1 more
openalex +1 more source
Mediterranean Journal of Hematology and Infectious Diseases, 2014 Splenic Marginal Zone Lymphoma is a disease with relatively indolent course, however, the optimal treatment strategy and outcome remains undefined. Lymphoproliferative disorders can develop in the setting of chronic infections and autoimmune diseases ...
Ricardo García-Muñoz
doaj
Preferential Dissemination of B-Cell Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma to the Splenic Marginal Zone [PDF]
, 1997 Ming‐Qing Du +9 more
openalex +1 more source
Multimodal Image Analysis of Chronic Leukemic Lymphoproliferative Disorders and the Hypothesis of »Single« and »Multiple« Programmed Stops in the Development of Typical and Atypical Forms of Leukemias and Lymphomas [PDF]
, 2010 The study consisted of morphometric analysis, assessment of the argyrophilic nucleolar organization region (AgNOR) characteristics, and image cytometry (ICM) in different tumor mass compartments: bone marrow (BM), peripheral blood (PB) and lymph nodes ...
Biljana Jelić Puškarić +5 more
core +2 more sources
Genetic characterization in tissue and cfDNA in marginal zone lymphomas [PDF]
, 2023 Ramón Díez-Feijoo +14 more
openalex +1 more source
Blood and Lymphatic Cancer: Targets and Therapy, 2014 Larissa Sena Teixeira Mendes,1 Ming-Qing Du,2 Estella Matutes,3 Andrew Wotherspoon11Histopathology Department, Royal Marsden Hospital, London, UK; 2Molecular Malignancy Laboratory and Department of Histopathology, University Hospital NHS Foundation Trust/
Teixeira Mendes LS +3 more
doaj
EClinicalMedicineSummary: Background: Marginal zone lymphomas (MZL), comprised of three unique but related subtypes, lack a unifying prognostic score applicable to all the patients in need for systemic chemotherapy and/or immunotherapy.
Luca Arcaini +34 more
doaj +1 more source
Crystal-storing histiocytosis associated with thymic extranodal marginal zone lymphoma [PDF]
, 2017 Jayalakshmi Balakrishna, Elaine S. Jaffe
openalex +1 more source
Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma [PDF]
, 2021 Panayiotis Panayiotidis +12 more
openalex +1 more source